Kevin K. Ariën
- Virology top 0.5%
- HIV Research and Treatment 32
- Infectious Diseases top 0.5%
- Viral Infections and Vectors 32
- HIV/AIDS drug development and treatment 22
- SARS-CoV-2 and COVID-19 Research 21
- HIV/AIDS Research and Interventions 19
- Microbiology top 2%
- Reproductive tract infections research 17
-
- Mosquito-borne diseases and control 35
- Malaria Research and Control 13
- Pharmaceutical Science top 5%
- Co-authors
- Guido VanhamEric J. ArtsJohan MíchielsKoen BartholomeeusenMarjan Van EsbroeckYoussef GaliMiguel E. Quiñones‐MateuLieselotte Cnops
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Kevin K. Ariën
114 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Virology 858
- Infectious Diseases 1.6k
- Microbiology 277
- Public Health, Environmental and Occupational Health 691
- Pharmaceutical Science 109
Countries citing papers authored by Kevin K. Ariën
This map shows the geographic impact of Kevin K. Ariën's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin K. Ariën with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin K. Ariën more than expected).
Fields of papers citing papers by Kevin K. Ariën
This network shows the impact of papers produced by Kevin K. Ariën. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin K. Ariën. The network helps show where Kevin K. Ariën may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin K. Ariën, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 40 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 28 | |
| 14 | 2021 | 27 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 22 | |
| 17 | 2019 | 55 | |
| 18 | 2016 | 8 | |
| 19 | 2014 | 2 | |
| 20 | 2010 | 56 |
About Kevin K. Ariën
Kevin K. Ariën is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 116 papers that have together received 2.5k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (35 papers), Viral Infections and Vectors (32 papers), HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (22 papers), SARS-CoV-2 and COVID-19 Research (21 papers), HIV/AIDS Research and Interventions (19 papers), Reproductive tract infections research (17 papers) and Malaria Research and Control (13 papers). The work is most often cited by research in Virology (858 citations), Infectious Diseases (1.6k citations) and Microbiology (277 citations). Kevin K. Ariën has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Guido Vanham, Eric J. Arts, Johan Míchiels, Koen Bartholomeeusen, Guido Vanham, Marjan Van Esbroeck, Youssef Gali, Miguel E. Quiñones‐Mateu, Lieselotte Cnops and Awet Abraha. Their work appears in journals such as Nature, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.